Sustained release pharmaceutical oral solid dosage form of dronedarone or one of its pharmaceutically acceptable salts

• 收藏
• 分享

专利权人:

发明人:

申请号：

EP11305874.7

公开号：

EP2543362A1

申请日:

2011.07.07

申请国别(地区):

EP

年份:

2013

代理人:

摘要：

The instant invention relates to a sustained release pharmaceutical oral solid dosage form comprising a therapeutically effective amount of dronedarone or pharmaceutically acceptable salts thereof adapted to release over a predetermined time period according to a profile of dissolution characterized in that an amount comprised between 55 and 85% of dronedarone or pharmaceutically acceptable salts thereof is liberated at 240 minutes.Preparation and application in therapeutics.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/